Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Polypeptide Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Merck Serono
Sanofi
Novartis
Roche
Ipsen PHarma Biotech
Ferring Pharmaceuticals
Lilly
Takeda
Asahi Kasei
SciClone Pharmaceuticals
AstraZeneca
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Injection
Nasal administration
Lung administration
Oral administration
Transdermal administration
Application:
Immunity Regulating Medicine (Allergy Infection and Immune)
Digestive System Drugs (Gastrointestinal Type)
Bone and Connective Tissue Types (Thyroid hormones Drug)
Gynecologic or Obstetric Drug
Tumor Drug
Urinary System Drug
Metabolic Drug (Insulin and Other Hypoglycemic Agents)
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Polypeptide Drug Industry Overview
-
1.1.1 Polypeptide Drug Market Scope and Market Segments
-
1.1.2 Polypeptide Drug Industry Characteristics
-
1.1.3 Global and China Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Polypeptide Drug Production Value and Growth Rate (2017-2028)
-
1.2 Global Polypeptide Drug Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Injection
-
1.2.2 Nasal administration
-
1.2.3 Lung administration
-
1.2.4 Oral administration
-
1.2.5 Transdermal administration
-
1.3 Global Polypeptide Drug Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Immunity Regulating Medicine (Allergy Infection and Immune)
-
1.3.2 Digestive System Drugs (Gastrointestinal Type)
-
1.3.3 Bone and Connective Tissue Types (Thyroid hormones Drug)
-
1.3.4 Gynecologic or Obstetric Drug
-
1.3.5 Tumor Drug
-
1.3.6 Urinary System Drug
-
1.3.7 Metabolic Drug (Insulin and Other Hypoglycemic Agents)
-
1.4 Market Analysis by Region
-
1.4.1 North America Polypeptide Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Polypeptide Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Polypeptide Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Polypeptide Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Polypeptide Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Polypeptide Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Polypeptide Drug Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Polypeptide Drug Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Polypeptide Drug Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Polypeptide Drug Industry Porter's Five Forces Model Analysis
-
2.2.3 Polypeptide Drug Industry PEST Analysis
-
2.3 Polypeptide Drug Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Polypeptide Drug Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Polypeptide Drug Industry
Chapter 3 Global and China Polypeptide Drug Market, by Manufacturer
-
3.1 Global and China Polypeptide Drug Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Polypeptide Drug Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Polypeptide Drug Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Polypeptide Drug Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Polypeptide Drug Market Top 3 Players
Chapter 4 Global and China Polypeptide Drug Market, by Type (2017-2028)
-
4.1 Polypeptide Drug Market Trend, by Type
-
4.2 Global Polypeptide Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Polypeptide Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Polypeptide Drug Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Polypeptide Drug Price Trend, by Type (2017-2028)
-
4.3 China Polypeptide Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Polypeptide Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Polypeptide Drug Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Polypeptide Drug Price Trend, by Type (2017-2028)
Chapter 5 Global and China Polypeptide Drug Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Polypeptide Drug Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Polypeptide Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Polypeptide Drug Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Polypeptide Drug Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Polypeptide Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Polypeptide Drug Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Polypeptide Drug Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Polypeptide Drug Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Polypeptide Drug Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Polypeptide Drug Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Polypeptide Drug Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Polypeptide Drug Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Polypeptide Drug Market Analysis
-
7.1 North America Polypeptide Drug Market, by Type
-
7.2 North America Polypeptide Drug Market, by Application
-
7.3 North America Polypeptide Drug Market Analysis and Forecast, by Country
-
7.3.1 United States Polypeptide Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Polypeptide Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Polypeptide Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Polypeptide Drug Market Analysis
-
8.1 Europe Polypeptide Drug Market, by Type
-
8.2 Europe Polypeptide Drug Market, by Application
-
8.3 Europe Polypeptide Drug Market Analysis and Forecast, by Country
-
8.3.1 Germany Polypeptide Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Polypeptide Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Polypeptide Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Polypeptide Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Polypeptide Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Polypeptide Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Polypeptide Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Polypeptide Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Polypeptide Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Polypeptide Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Polypeptide Drug Market Analysis
-
9.1 APAC Polypeptide Drug Market, by Type
-
9.2 APAC Polypeptide Drug Market, by Application
-
9.3 APAC Polypeptide Drug Market Analysis and Forecast, by Country
-
9.3.1 China Polypeptide Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Polypeptide Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Polypeptide Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Polypeptide Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Polypeptide Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Polypeptide Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Polypeptide Drug Market Analysis
-
10.1 Latin America, Middle East and Africa Polypeptide Drug Market, by Type
-
10.2 Latin America, Middle East and Africa Polypeptide Drug Market, by Application
-
10.3 Latin America, Middle East and Africa Polypeptide Drug Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Polypeptide Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Polypeptide Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Polypeptide Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Polypeptide Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Polypeptide Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Polypeptide Drug Company Profiles
-
11.1 Merck Serono
-
11.1.1 Merck Serono Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Merck Serono Polypeptide Drug Product Profiles, Application and Specification
-
11.1.3 Merck Serono Polypeptide Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Sanofi
-
11.2.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Sanofi Polypeptide Drug Product Profiles, Application and Specification
-
11.2.3 Sanofi Polypeptide Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Novartis
-
11.3.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Novartis Polypeptide Drug Product Profiles, Application and Specification
-
11.3.3 Novartis Polypeptide Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Roche
-
11.4.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Roche Polypeptide Drug Product Profiles, Application and Specification
-
11.4.3 Roche Polypeptide Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Ipsen PHarma Biotech
-
11.5.1 Ipsen PHarma Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Ipsen PHarma Biotech Polypeptide Drug Product Profiles, Application and Specification
-
11.5.3 Ipsen PHarma Biotech Polypeptide Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Ferring Pharmaceuticals
-
11.6.1 Ferring Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Ferring Pharmaceuticals Polypeptide Drug Product Profiles, Application and Specification
-
11.6.3 Ferring Pharmaceuticals Polypeptide Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Lilly
-
11.7.1 Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Lilly Polypeptide Drug Product Profiles, Application and Specification
-
11.7.3 Lilly Polypeptide Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Takeda
-
11.8.1 Takeda Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Takeda Polypeptide Drug Product Profiles, Application and Specification
-
11.8.3 Takeda Polypeptide Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Asahi Kasei
-
11.9.1 Asahi Kasei Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Asahi Kasei Polypeptide Drug Product Profiles, Application and Specification
-
11.9.3 Asahi Kasei Polypeptide Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 SciClone Pharmaceuticals
-
11.10.1 SciClone Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 SciClone Pharmaceuticals Polypeptide Drug Product Profiles, Application and Specification
-
11.10.3 SciClone Pharmaceuticals Polypeptide Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 AstraZeneca
-
11.11.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 AstraZeneca Polypeptide Drug Product Profiles, Application and Specification
-
11.11.3 AstraZeneca Polypeptide Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Polypeptide Drug Industry Investment Prospect and Risk Assessment
-
12.1 Polypeptide Drug Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Polypeptide Drug Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Global Polypeptide Drug Production Value and Growth Rate (2017-2028)
-
Figure China Polypeptide Drug Production Value and Growth Rate (2017-2028)
-
Figure Global Polypeptide Drug Market Size and Growth Rate of Injection (2017-2028)
-
Figure Global Polypeptide Drug Market Size and Growth Rate of Nasal administration (2017-2028)
-
Figure Global Polypeptide Drug Market Size and Growth Rate of Lung administration (2017-2028)
-
Figure Global Polypeptide Drug Market Size and Growth Rate of Oral administration (2017-2028)
-
Figure Global Polypeptide Drug Market Size and Growth Rate of Transdermal administration (2017-2028)
-
Figure Global Polypeptide Drug Market Size and Growth Rate of Immunity Regulating Medicine (Allergy Infection and Immune) (2017-2028)
-
Figure Global Polypeptide Drug Market Size and Growth Rate of Digestive System Drugs (Gastrointestinal Type) (2017-2028)
-
Figure Global Polypeptide Drug Market Size and Growth Rate of Bone and Connective Tissue Types (Thyroid hormones Drug) (2017-2028)
-
Figure Global Polypeptide Drug Market Size and Growth Rate of Gynecologic or Obstetric Drug (2017-2028)
-
Figure Global Polypeptide Drug Market Size and Growth Rate of Tumor Drug (2017-2028)
-
Figure Global Polypeptide Drug Market Size and Growth Rate of Urinary System Drug (2017-2028)
-
Figure Global Polypeptide Drug Market Size and Growth Rate of Metabolic Drug (Insulin and Other Hypoglycemic Agents) (2017-2028)
-
Figure North America Polypeptide Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Polypeptide Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Polypeptide Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Polypeptide Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Polypeptide Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Polypeptide Drug Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Polypeptide Drug Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Polypeptide Drug Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Polypeptide Drug Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Polypeptide Drug Market Share, by Manufacturer in 2021
-
Figure Global and China Polypeptide Drug Market Share, by Manufacturer in 2022
-
Table Global Polypeptide Drug Sales Volume, by Type (2017-2028)
-
Table Global Polypeptide Drug Sales Volume Share, by Type (2017-2028)
-
Figure Global Polypeptide Drug Sales Volume Share, by Type (2017-2028)
-
Table Global Polypeptide Drug Sales Value, by Type (2017-2028)
-
Table Global Polypeptide Drug Sales Value Share, by Type (2017-2028)
-
Figure Global Polypeptide Drug Price Trend, by Type (2017-2028)
-
Table China Polypeptide Drug Sales Volume, by Type (2017-2028)
-
Table China Polypeptide Drug Sales Volume Share, by Type (2017-2028)
-
Figure China Polypeptide Drug Sales Volume Share, by Type (2017-2028)
-
Table China Polypeptide Drug Sales Value, by Type (2017-2028)
-
Table China Polypeptide Drug Sales Value Share, by Type (2017-2028)
-
Figure China Polypeptide Drug Price Trend, by Type (2017-2028)
-
Table Global Polypeptide Drug Sales Volume, by Application (2017-2028)
-
Table Global Polypeptide Drug Sales Volume Share, by Application (2017-2028)
-
Figure Global Polypeptide Drug Sales Volume Share, by Application (2017-2028)
-
Table Global Polypeptide Drug Sales Value, by Application (2017-2028)
-
Table Global Polypeptide Drug Sales Value Share, by Application (2017-2028)
-
Figure Global Polypeptide Drug Sales Value Share, by Application (2017-2028)
-
Table China Polypeptide Drug Sales Volume, by Application (2017-2028)
-
Table China Polypeptide Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Polypeptide Drug Sales Volume Share, by Application (2017-2028)
-
Table China Polypeptide Drug Sales Value, by Application (2017-2028)
-
Table China Polypeptide Drug Sales Value Share, by Application (2017-2028)
-
Figure China Polypeptide Drug Sales Value Share, by Application (2017-2028)
-
Figure China Polypeptide Drug Production, Import, Consumption and Export (2017-2022)
-
Figure North America Polypeptide Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Polypeptide Drug Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Polypeptide Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Polypeptide Drug Production, Import, Consumption and Export (2017-2022)
-
Table North America Polypeptide Drug Sales Volume, by Type (2017-2028)
-
Table North America Polypeptide Drug Sales Volume Share, by Type (2017-2028)
-
Figure North America Polypeptide Drug Sales Volume Share, by Type (2017-2028)
-
Table North America Polypeptide Drug Sales Volume, by Application (2017-2028)
-
Table North America Polypeptide Drug Sales Volume Share, by Application (2017-2028)
-
Figure North America Polypeptide Drug Sales Volume Share, by Application (2017-2028)
-
Figure United States Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure United States Polypeptide Drug Sales Value and Growth Rate (2017-2028)
-
Figure Canada Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Polypeptide Drug Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Polypeptide Drug Sales Value and Growth Rate (2017-2028)
-
Table Europe Polypeptide Drug Sales Volume, by Type (2017-2028)
-
Table Europe Polypeptide Drug Sales Volume Share, by Type (2017-2028)
-
Figure Europe Polypeptide Drug Sales Volume Share, by Type (2017-2028)
-
Table Europe Polypeptide Drug Sales Volume, by Application (2017-2028)
-
Table Europe Polypeptide Drug Sales Volume Share, by Application (2017-2028)
-
Figure Europe Polypeptide Drug Sales Volume Share, by Application (2017-2028)
-
Figure Germany Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Polypeptide Drug Sales Value and Growth Rate (2017-2028)
-
Figure UK Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure UK Polypeptide Drug Sales Value and Growth Rate (2017-2028)
-
Figure France Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure France Polypeptide Drug Sales Value and Growth Rate (2017-2028)
-
Figure Italy Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Polypeptide Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Polypeptide Drug Sales Value and Growth Rate (2017-2028)
-
Figure Spain Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Polypeptide Drug Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Polypeptide Drug Sales Value and Growth Rate (2017-2028)
-
Figure Poland Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Polypeptide Drug Sales Value and Growth Rate (2017-2028)
-
Figure Russia Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Polypeptide Drug Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Polypeptide Drug Sales Value and Growth Rate (2017-2028)
-
Table APAC Polypeptide Drug Sales Volume, by Type (2017-2028)
-
Table APAC Polypeptide Drug Sales Volume Share, by Type (2017-2028)
-
Figure APAC Polypeptide Drug Sales Volume Share, by Type (2017-2028)
-
Table APAC Polypeptide Drug Sales Volume, by Application (2017-2028)
-
Table APAC Polypeptide Drug Sales Volume Share, by Application (2017-2028)
-
Figure APAC Polypeptide Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Polypeptide Drug Sales Value and Growth Rate (2017-2028)
-
Figure Japan Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Polypeptide Drug Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Polypeptide Drug Sales Value and Growth Rate (2017-2028)
-
Figure India Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure India Polypeptide Drug Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Polypeptide Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Polypeptide Drug Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Polypeptide Drug Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Polypeptide Drug Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Polypeptide Drug Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Polypeptide Drug Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Polypeptide Drug Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Polypeptide Drug Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Polypeptide Drug Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Polypeptide Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Polypeptide Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Polypeptide Drug Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Polypeptide Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Polypeptide Drug Sales Value and Growth Rate (2017-2028)
-
Table Merck Serono Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Merck Serono Product Profiles, Application and Specification
-
Table Merck Serono Polypeptide Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi Product Profiles, Application and Specification
-
Table Sanofi Polypeptide Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Polypeptide Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Roche Product Profiles, Application and Specification
-
Table Roche Polypeptide Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Ipsen PHarma Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Ipsen PHarma Biotech Product Profiles, Application and Specification
-
Table Ipsen PHarma Biotech Polypeptide Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Ferring Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Ferring Pharmaceuticals Product Profiles, Application and Specification
-
Table Ferring Pharmaceuticals Polypeptide Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Lilly Product Profiles, Application and Specification
-
Table Lilly Polypeptide Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Takeda Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Takeda Product Profiles, Application and Specification
-
Table Takeda Polypeptide Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Asahi Kasei Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Asahi Kasei Product Profiles, Application and Specification
-
Table Asahi Kasei Polypeptide Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table SciClone Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table SciClone Pharmaceuticals Product Profiles, Application and Specification
-
Table SciClone Pharmaceuticals Polypeptide Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AstraZeneca Product Profiles, Application and Specification
-
Table AstraZeneca Polypeptide Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
